IMCS creates, manufactures and distributes next-generation biotechnology products to clinical and forensic toxicology, academic research facilities, US Federal Government agencies and health science companies. Their portfolio consists of two major product lines:
IMCSzyme® is a genetically modified beta-glucuronidase used to detect a wide range of drugs by hydrolyzing glucuronides in biological fluids. After rapid hydrolysis with IMCSzyme, samples can be analyzed by immunoassay, mass spectrometry, and high-performance liquid chromatography. IMCSzyme hydrolyzes multiple drug classes with higher efficiency as compared to other available enzymes.
IMCStips® is a patented solid-phase extraction technology used in the field of proteomics. IMCS‘ dispersive solid-phase extraction (dSPE) technology contains loose resin, which achieves higher binding capacities and consistent, reproducible results.
Lucerna-Chem is the official Swiss distributor, enabling you convenient domestic orders for all products listed in the webshop.